Division 47

Council Regulation (EEC) No 2309/93 of 22 July 1993 laying down Community procedures for the authorisation and suspension of medicinal products for human and veterinary use and establishing a European Agency for the Evaluation of Medicinal Products ^f1.

Articles 72 and 73 shall be replaced by the following:

‘Article 72

1.

The Commission shall be assisted by:

• the Standing Committee on Medicinal Products for Human Use, in the case of matters relating to medicinal products for human use, and

• the Standing Committee on Veterinary Medicinal Products, in the case of matters relating to veterinary medicinal products.

2.

Where reference is made to this Article, Articles 5 and 7 of Decision 1999/468/EC ^f2 shall apply.

The period laid down in Article 5(6) of Decision 1999/468/EC shall be set at three months.

3.

The committees shall adopt their rules of procedure.

Article 73

1.

The Commission shall be assisted by:

• the Standing Committee on Medicinal Products for Human Use, in the case of matters relating to medicinal products for human use, and

• the Standing Committee on Veterinary Medicinal Products, in the case of matters relating to veterinary medicinal products.

2.

Where reference is made to this Article, Article 5 and 7 of Decision 1999/468/EC shall apply.

The period laid down in Article 5(6) of Decision 1999/468/EC shall be set at three months.’